The US Food and Drug Administration (FDA) has given 510(k) clearance to ActiViews to market its CT-Guide Needle Guidance System for liver interventions. CT-Guide navigation is designed to assist physicians during CT-guided interventional diagnostic and therapeutic procedures such as percutaneous biopsies, ablations, and marker placements in the lung and liver. The system features a single-use miniature video camera that is easily affixed onto standard interventional instruments, a patented sterile registration sticker, and proprietary 3D software that is viewed on a HD flat panel monitor mounted on a mobile workstation. CT-Guide navigation allows physicians to determine the location of the navigated instrument in relation to the 3D space of the CT images and the desired target, continuously displaying the location of the instrument and its planned path on the CT image of the patient’s anatomy.
One-third of imaging tests performed to evaluate patients for possible pulmonary embolism may be unnecessary, a prospective observational study found. Among patients who had a CT scan or other imaging study as part of a work-up for pulmonary embolism, 32% (95% CI 31 to 34) of the tests would have been classified as "avoidable" according to a measure endorsed by the National Quality Forum, reported Christopher Kabrhel, MD, of Harvard University in Boston, and colleagues.
St. Jude Medical, Inc. (STJ), a global medical device company, today announced it has received U.S. Food and Drug Administration (FDA) clearance and will immediately launch the AMPLATZER™ Vascular Plug 4 (AVP 4) for use in transcatheter embolization procedures (minimally invasive procedures that involve the selective blocking of blood vessels) within the peripheral vasculature. Approximately 50,000 peripheral embolizations are performed each year in the United States.
To enable hospitals to keep pace with the latest technological advances and offer better patient care and improved workflow while containing costs, Toshiba America Medical Systems, Inc. announces the availability of VeloCT. This console upgrade includes new enhancements for patient safety, dose management and workflow for existing Aquilion™ 32, Aquilion 64 and Aquilion CX CT systems manufactured between 2006 and 2012.
Siemens Healthcare (SI) has announced that the Food and Drug Administration (FDA) has cleared the SOMATOM® Perspective – an advanced 128-slice computed tomography (CT) scanner engineered to drive efficiency and reduce costs.
Nordion has announced that organisers of the World Congress on Interventional Oncology (WCIO) 2012 hosted a live administration of the company s TheraSphere Yttrium-90 (Y-90) glass microsphere liver cancer treatment.
BTG has announced that following positive results of its 15-year experience between 2003 and 2017 with TheraSphere, Northwestern University, Illinois, USA, has adopted Y-90 transarterial radioembolization (TARE; also known as radioembolization, or selective internal radiation therapy [SIRT]) with TheraSphere as the primary transarterial locoregional therapy for patients with hepatocellular carcinoma (HCC) limited to the liver.
A prospective, randomised single-centre study that set out to compare the safety and efficacy of vascular plugs and fibred platinum coils for embolization in pelvic congestion syndrome has shown that while both devices resulted in successful embolization, plugs were associated with decreased fluoroscopy time and radiation dose
Guerbet has announced that it has entered into an agreement under which it will acquire Israeli company Accurate Medical, which specialises in the development of microcatheters used in interventional radiology.
Viz.ai has announced the CE mark of its direct-to-intervention system, ContaCT, a novel approach to stroke care that automatically analyses brain CTs and notifies a specialist that a suspected large vessel occlusion has been identified.
The upcoming annual meeting of the European Society of Radiology (ESR; 28 February – March 4, 2018, in Vienna, Austria) has adopted the motto ‘Diverse and United’ and will feature a brand new programme format titled “Interventional Radiology at the Cube”.
A new study has found that a test that identifies circulating tumour cells (CTCs) present in the bloodstream can detect colorectal cancer at an early stage, with accuracy ranging from 84 to 88%. Collection of CTCs from the blood is one form of “liquid biopsy.”
Emergency mechanical thrombectomy dramatically increases a stroke patient’s chance of a full recovery. The UK does not have enough skilled doctors to provide the procedure. NHS England plans to roll out the technique nationally, but will need at least another 50 extra specially trained radiologists.
Teleflex has announced the completion of its previously announced acquisition of NeoTract.
Global specialist healthcare company BTG has highlighted the commencement of the KNOCOUT PE study. The KNOCOUT PE study will measure how hospitals and patients are benefitting from a new standard of care in the treatment of pulmonary embolism utilising the company’s EKOS therapy with faster and safer protocols, following the encouraging results of the OPTALYSE PE study.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos